0.31% 0.069

Castle Biosciences Inc (CSTL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CSTL? Forum Prognose

Finanzdaten der Castle Biosciences Inc-Aktie (CSTL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.78% 87.01	83.04	86.19	87.99	85.78
Cost Of Revenue	2.08% 18.32	18.70	17.63	16.38	15.61
Gross Profit	6.77% 68.69	64.34	68.56	71.61	70.17
Operating Expenses	1.94% 72.52	71.14	72.81	99.53	65.09
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	1.10% 90.84	89.85	90.44	115.92	80.70
Operating Income/Loss	43.75% -3.827	-6.804	-4.251	-27.93	5.079
Income/Loss From Continuing Operations Before Tax	4.78% 87.01	83.04	4.523	-25.85	85.78
Income Tax Expense/Benefit, Deferred	881.90% -0.907	0.116	-4.667	-0.77	5.25
Income Tax Expense/Benefit	432.17% -0.382	0.115	-4.666	-0.423	6.013
Income/Loss From Continuing Operations After Tax	365.47% -2.332	-0.501	4.523	-25.85	2.269
Net Income/Loss	365.47% -2.332	-0.501	4.523	-25.85	2.269
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.59% 0.118	29.07	28.91	28.61	27.84
Diluted Average Shares	99.59% 0.118	29.07	29.55	28.61	29.40
Basic Earnings Per Share	250.00% -0.07	-0.02	0.16	-0.90	0.08
Diluted Earnings Per Share	250.00% -0.07	-0.02	0.15	-0.90	0.08
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

$264.90

0.76%

DGX

$199.32

0.64%

MTD

$1,175.83

0.74%

NTRA

$188.84

0.09%

IQV

$164.81

1.19%

WAT

$286.06

0.95%